Cardiff Oncology (CRDF) Short Interest Ratio & Short Volume

$2.70

+0.14 (+5.47%)

(As of 01:26 PM ET)

Cardiff Oncology Short Interest Data

Cardiff Oncology (CRDF) has a short interest of 6.90 million shares. This marks a 2.68% increase in short interest from the previous month. The short interest ratio (days to cover) is 12.7, indicating that it would take 12.7 days of the average trading volume of 983,105 shares to cover all short positions.

Current Short Interest: 6,900,000 shares
Previous Short Interest: 6,720,000 shares
Change Vs. Previous Month: +2.68%
Dollar Volume Sold Short: $15.94 million
Short Interest Ratio: 12.7 Days to Cover
Last Record Date: August 31, 2024

Outstanding Shares: 46,550,000 shares
Percentage of Shares Shorted: 14.82%
Today's Trading Volume: 369,933 shares
Average Trading Volume: 983,105 shares
Today's Volume Vs. Average: 38%

Short Selling Cardiff Oncology?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cardiff Oncology and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

CRDF Short Interest Over Time

CRDF Days to Cover Over Time

CRDF Percentage of Float Shorted Over Time

Ad Monetary Gold

Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

Cardiff Oncology Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/31/2024	6,900,000 shares	$15.94 million	+2.7%	N/A	12.7	$2.31
8/15/2024	6,720,000 shares	$16.06 million	+16.3%	N/A	11.7	$2.39
7/31/2024	5,780,000 shares	$13.53 million	+12.9%	N/A	9.7	$2.34
7/15/2024	5,120,000 shares	$12.85 million	+21.3%	N/A	7.7	$2.51
6/30/2024	4,220,000 shares	$9.37 million	+4.5%	N/A	5.8	$2.22
6/15/2024	4,040,000 shares	$10.91 million	-9.4%	N/A	5.4	$2.70
Get the Latest News and Ratings for CRDF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter.
5/31/2024	4,460,000 shares	$14.18 million	-3.5%	N/A	4.7	$3.18
5/15/2024	4,620,000 shares	$16.49 million	+4.5%	N/A	2.4	$3.57
4/30/2024	4,420,000 shares	$19.27 million	+10.8%	N/A	2.3	$4.36
4/15/2024	3,990,000 shares	$21.07 million	+17.0%	N/A	2.2	$5.28
3/31/2024	3,410,000 shares	$18.21 million	+21.4%	N/A	2	$5.34
3/15/2024	2,810,000 shares	$14.13 million	+144.4%	N/A	1.8	$5.03
2/29/2024	1,150,000 shares	$2.03 million	-3.4%	N/A	0.9	$1.77
2/15/2024	1,190,000 shares	$2.08 million	-7.8%	N/A	7.6	$1.75
1/31/2024	1,290,000 shares	$2.01 million	+13.2%	N/A	7.5	$1.56
1/15/2024	1,140,000 shares	$1.93 million	-13.6%	N/A	6.5	$1.69
12/31/2023	1,320,000 shares	$1.95 million	-2.2%	N/A	6.4	$1.48
12/15/2023	1,350,000 shares	$1.89 million	-6.9%	N/A	2	$1.40
11/30/2023	1,450,000 shares	$1.78 million	-9.4%	N/A	2.1	$1.23
11/15/2023	1,600,000 shares	$1.94 million	-1.8%	N/A	2.3	$1.21
10/31/2023	1,630,000 shares	$1.74 million	+6.5%	N/A	2.2	$1.07
10/15/2023	1,530,000 shares	$1.70 million	-24.6%	N/A	1.4	$1.11
9/30/2023	2,030,000 shares	$2.82 million	+201.6%	N/A	1.9	$1.39
9/15/2023	673,000 shares	$1.16 million	+25.4%	N/A	1.1	$1.73
8/31/2023	536,500 shares	$987,160.00	-19.5%	N/A	0.9	$1.84
8/15/2023	666,400 shares	$1.33 million	+28.7%	N/A	1.2	$2.00
7/31/2023	517,700 shares	$916,329.00	+5.0%	N/A	1	$1.77
7/15/2023	492,900 shares	$694,989.00	-8.2%	N/A	3.3	$1.41
6/30/2023	537,000 shares	$789,390.00	+1.0%	N/A	3.5	$1.47
6/15/2023	531,600 shares	$845,244.00	-1.7%	N/A	3.4	$1.59
5/31/2023	541,000 shares	$871,010.00	-0.2%	N/A	2.9	$1.61
5/15/2023	542,300 shares	$949,025.00	-12.1%	N/A	2.7	$1.75
4/30/2023	616,900 shares	$1.07 million	-2.4%	N/A	2.9	$1.74
4/15/2023	632,000 shares	$941,680.00	+1.2%	N/A	3	$1.49
3/31/2023	624,300 shares	$1.03 million	-7.3%	N/A	2.6	$1.65
3/15/2023	673,600 shares	$1.16 million	-1.6%	N/A	2.6	$1.72
2/28/2023	684,400 shares	$1.18 million	-14.6%	N/A	2.9	$1.73
2/15/2023	801,300 shares	$1.50 million	-11.6%	N/A	3.3	$1.87
1/31/2023	905,900 shares	$1.62 million	-9.4%	N/A	3.6	$1.79
1/15/2023	1,000,000 shares	$1.53 million	-8.3%	N/A	3.9	$1.53
You won’t believe what this ex-Wall Street insider discovered about the election (Ad) One ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered something surprising about the presidential elections… It turns out that for the past 64 years, the stock market has soared during election seasons - regardless of whether a Democrat or Republican is elected. In other words, if you're sitting on the sidelines because you're worried about how the market will react to a Trump or Kamala win, you could be missing out on some serious profits. Learn all about it here.
12/30/2022	1,090,000 shares	$1.53 million	-5.2%	N/A	4.6	$1.40
12/15/2022	1,150,000 shares	$1.61 million	-2.5%	N/A	4.4	$1.40
11/30/2022	1,180,000 shares	$1.88 million	-1.7%	N/A	2.3	$1.59
11/15/2022	1,200,000 shares	$1.61 million	-7.7%	N/A	2.2	$1.34
10/31/2022	1,300,000 shares	$2.12 million	-19.8%	N/A	2.2	$1.63
10/15/2022	1,620,000 shares	$2.49 million	-10.0%	N/A	2.6	$1.54
9/30/2022	1,800,000 shares	$2.77 million	-18.2%	N/A	2.7	$1.54
9/15/2022	2,200,000 shares	$3.67 million	+9.5%	N/A	2.5	$1.67
8/31/2022	2,010,000 shares	$5.41 million	-7.4%	N/A	2.2	$2.69
8/15/2022	2,170,000 shares	$6.55 million	+4.3%	N/A	2.3	$3.02
7/31/2022	2,080,000 shares	$4.60 million	-8.4%	N/A	2.2	$2.21
7/15/2022	2,270,000 shares	$6.13 million	-12.0%	N/A	2.2	$2.70
6/30/2022	2,580,000 shares	$5.68 million	-27.1%	N/A	2.5	$2.20
6/15/2022	3,540,000 shares	$5.95 million	+8.6%	N/A	3.8	$1.68
5/31/2022	3,260,000 shares	$4.40 million	-9.9%	N/A	4.3	$1.35
5/15/2022	3,620,000 shares	$4.85 million	+6.2%	N/A	5.4	$1.34
4/30/2022	3,410,000 shares	$4.57 million	+37.5%	N/A	4.9	$1.34
4/15/2022	2,480,000 shares	$4.81 million	-1.6%	N/A	3.4	$1.94
3/31/2022	2,520,000 shares	$6.25 million	+6.3%	N/A	3.1	$2.48
3/15/2022	2,370,000 shares	$5.38 million	+9.7%	N/A	2.8	$2.27
2/28/2022	2,160,000 shares	$5.81 million	-2.7%	N/A	2.6	$2.69
2/15/2022	2,220,000 shares	$7.04 million	-28.4%	N/A	2.8	$3.17
1/31/2022	3,100,000 shares	$10.48 million	-15.8%	N/A	2.8	$3.38
1/15/2022	3,680,000 shares	$25.24 million	+32.4%	N/A	3.8	$6.86
12/31/2021	2,780,000 shares	$16.71 million	+4.1%	7.5%	3.5	$6.01
12/15/2021	2,670,000 shares	$15.41 million	-9.5%	7.2%	3.3	$5.77
11/30/2021	2,950,000 shares	$16.58 million	+17.1%	8.0%	2.5	$5.62
11/15/2021	2,520,000 shares	$13.66 million	-7.4%	N/A	2	$5.42
10/29/2021	2,720,000 shares	$15.97 million	+1.5%	7.3%	2.8	$5.87
10/15/2021	2,680,000 shares	$17.15 million	+0.8%	7.2%	2.7	$6.40
9/30/2021	2,660,000 shares	$17.72 million	+3.5%	7.1%	2.5	$6.66
9/15/2021	2,570,000 shares	$16.81 million	-18.9%	6.9%	2.2	$6.54
8/31/2021	3,170,000 shares	$23.24 million	+11.6%	8.5%	2.9	$7.33
8/13/2021	2,840,000 shares	$16.30 million	+0.7%	7.6%	4.5	$5.74
7/30/2021	2,820,000 shares	$15.00 million	-2.4%	8.1%	4.3	$5.32
7/15/2021	2,890,000 shares	$17.28 million	-10.8%	8.3%	4.3	$5.98
6/30/2021	3,240,000 shares	$21.55 million	+24.6%	9.3%	4.9	$6.65
6/15/2021	2,600,000 shares	$20.80 million	-6.8%	7.4%	4.5	$8.00
5/28/2021	2,790,000 shares	$23.44 million	-10.0%	8.0%	4.1	$8.40
5/14/2021	3,100,000 shares	$26.32 million	+11.9%	9.0%	3.7	$8.49
4/30/2021	2,770,000 shares	$26.34 million	+8.6%	8.1%	2.8	$9.51
4/15/2021	2,550,000 shares	$22.44 million	-3.8%	7.6%	1.9	$8.80
3/31/2021	2,650,000 shares	$24.12 million	-51.0%	7.9%	1.5	$9.10
3/15/2021	5,410,000 shares	$58.70 million	+0.9%	16.1%	2.8	$10.85
2/26/2021	5,360,000 shares	$52.26 million	-9.9%	15.9%	2.8	$9.75
2/12/2021	5,950,000 shares	$84.73 million	-8.2%	18.6%	3.2	$14.24
1/29/2021	6,480,000 shares	$75.17 million	+10.8%	20.1%	3.7	$11.60
1/15/2021	5,850,000 shares	$114.48 million	No Change	18.1%	3.7	$19.57

CRDF Short Interest - Frequently Asked Questions

What is Cardiff Oncology's current short interest?: Short interest is the volume of Cardiff Oncology shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 6,900,000 shares of CRDF short. Learn More on Cardiff Oncology's current short interest.
What is a good short interest ratio for Cardiff Oncology?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDF shares currently have a short interest ratio of 13.0. Learn More on Cardiff Oncology's short interest ratio.
Is Cardiff Oncology's short interest increasing or decreasing?: Cardiff Oncology saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 6,900,000 shares, an increase of 2.7% from the previous total of 6,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Cardiff Oncology's short interest compare to its competitors?: Here is how the short interest of companies in the sector of "medical" compare to Cardiff Oncology: Agenus Inc. (13.67%), Precision BioSciences, Inc. (6.33%), Athira Pharma, Inc. (2.80%), Poseida Therapeutics, Inc. (4.02%), Adaptimmune Therapeutics plc (2.67%), Aura Biosciences, Inc. (3.11%), biote Corp. (3.93%), Fate Therapeutics, Inc. (13.32%), Aquestive Therapeutics, Inc. (11.86%), Korro Bio, Inc. (4.87%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.
What does it mean to sell short Cardiff Oncology stock?: Short selling CRDF is an investing strategy that aims to generate trading profit from Cardiff Oncology as its price is falling. CRDF shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Cardiff Oncology?: A short squeeze for Cardiff Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDF, which in turn drives the price of the stock up even further.
How often is Cardiff Oncology's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDF, twice per month. The most recent reporting period available is August, 31 2024.